Noteworthy

Apr 13, 2018
Pharmaceutical Executive
Amid rapid shifts in technology and consumer engagement, Lisa Henderson explores how new models in hiring and recruitment are reshaping biopharma’s future talent path.
Apr 10, 2018
Jo Pisani and Cynthia Chan outline the key legal considerations for post-deal integration.
Apr 10, 2018
Pharmaceutical Executive
Practitioners in the field of HEOR training and education outline how the best courses are responding to advancing industry needs. Julian Upton reports.
Apr 10, 2018
Pharmaceutical Executive
Senior leaders in the life sciences share stories on making the jump from the pharma to biotech worlds—and the innate drivers behind such moves.
Apr 09, 2018
Pharmaceutical Executive
This article shares practical advice, best practices, and real-world examples of how to hire talent for a successful commercial launch.
Apr 09, 2018
Pharmaceutical Executive
FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion.
Apr 08, 2018
Pharmaceutical Executive
Three ways AR can bolster pharma commercialization strategies. Arno Sosna reports.
Apr 07, 2018
Pharmaceutical Executive
The role of the medical affairs professional in the biopharma hierarchy has grown considerably, but challenges remain in its ascent to true strategic partner with the C-suite, writes Lisa Henderson.
Apr 06, 2018
Without considering the organizational and talent aspects of change, companies put themselves at risk for poor employee engagement, loss of talent, and ultimately, failed business initiatives, writes Viq Prevaaz.
Mar 22, 2018
Jin Zhang looks at the Chinese pharma companies that received FDA ANDA approvals in 2017 and discusses how the country's industry is poised for further breakthrough.
native1_300x100
lorem ipsum